4.5 Article

Statins Reduce Amyloid β-Peptide Production by Modulating Amyloid Precursor Protein Maturation and Phosphorylation Through a Cholesterol-Independent Mechanism in Cultured Neurons

期刊

NEUROCHEMICAL RESEARCH
卷 38, 期 3, 页码 589-600

出版社

SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s11064-012-0956-1

关键词

A beta; APP; Cholesterol; Neuron; Phosphorylation; Statin

资金

  1. Ministry of Health, Labor, and Welfare, Japan
  2. Ministry of Education, Culture, Sports, Science and Technology, Japan
  3. Grants-in-Aid for Scientific Research [24591249, 22590951] Funding Source: KAKEN

向作者/读者索取更多资源

Statins, 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors, have been reported to attenuate amyloid-beta peptide (A beta) production in various cellular models. However, the mechanisms by which statins affect neuronal A beta production have not yet been clarified. Here, we investigated this issue in rat primary cortical neurons using two statins, pitavastatin (PV) and atorvastatin (AV). Treatment of neurons with 0.2-2.5 mu M PV or AV for 4 days induced a concentration- and time-dependent reduction in the secretion of both A beta 40 and A beta 42. Moreover, Western blot analyses of cell lysates showed that treatment with PV or AV significantly reduced expression levels of the mature form of amyloid precursor protein (APP) and Thr668-phosphorylated APP (P-APP), but not immature form of APP; the decreases in P-APP levels were more notable than those of mature APP levels. The statin treatment did not alter expression of BACE1 (beta-site APP-cleaving enzyme 1) or gamma-secretase complex proteins (presenilin 1, nicastrin, APH-1, and PEN-2). In neurons overexpressing APP via recombinant adenoviruses, PV or AV similarly reduced A beta secretion and the levels of mature APP and P-APP. Statins also markedly reduced cellular cholesterol content in neurons in a concentration-dependent manner. Co-treatment with mevalonate reversed the statin-induced decreases in A beta secretion and mature APP and P-APP levels, whereas co-treatment with cholesterol did not, despite recovery of cellular cholesterol levels. Finally, cell-surface biotinylation experiments revealed that both statins significantly reduced the levels of cell-surface P-APP without changing those of cell surface mature APP. These results suggest that statins reduce A beta production by selectively modulating APP maturation and phosphorylation through a mechanism independent of cholesterol reduction in cultured neurons.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据